Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04120064 · ClinicalTrials.gov registry record · Phase 1
Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol
A Phase 1 study, sponsored by Parkview Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT04120064 is a Phase 1 study that was terminated before completion, run by Parkview Medical Center. The registered enrollment target is 60 participants.
The verdict
NCT04120064, a Phase 1 study, was terminated before completion, sponsored by Parkview Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
Comparing two treatment regimens (solitary large dose vs daily smaller dose) in patients diagnosed with vitamin D deficiency.
Interventions
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2021-01-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04120064
The ClinicalTrials.gov registry entry for NCT04120064 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Parkview Medical Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholecalciferol is the first listed.
NCT04120064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04120064 about?
NCT04120064 is a clinical study titled "Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol". Comparing two treatment regimens (solitary large dose vs daily smaller dose) in patients diagnosed with vitamin D deficiency.
What is the current status of trial NCT04120064?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2019-01-25. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT04120064?
The interventions under investigation include: Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT04120064?
This trial is sponsored by Parkview Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.